With the increasing popularity of alternative \u00a0investments, in particular in the areas of private equity, \u00a0private debt and real estate, we have witnessed that \u00a0there is more demand in realising such investments via \u00a0Luxembourg alternative investment fund structures \u00a0(the \u201cAIFs\u201d) by international eligible investors. In the EU, \u00a0AIFs were introduced by the Alternative Investment \u00a0Fund Manager Directive (Directive 2011\/61\/EU, the \u201cAIFM Directive\u201d), which regulates managers of funds other than those under the Undertakings for Collective Investments in Transferable Securities Directive (Directive 2009\/65\/EC).<\/p>\n<\/p>\n
The purpose of this article is to introduce the particular points to be examined during the legal due diligence for investing in a Luxembourg AIF structure.<\/p>\n<\/p>\n
Published by Global Fund Media, the article is part of the new edition of the issue Hedgeweek | Private Equity Wire – Luxembourg in Focus.<\/p>\n<\/p>\n
GSK Stockmann contributed to the publication with Marcus Peter (Partner at GSK Stockmann in Luxembourg) and Jingquan Li (Associate at GSK Stockmann in Luxembourg) as authors. The article is available for download as a PDF file; the whole edition is free to access\u00a0online<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" With the increasing popularity of alternative \u00a0investments, in particular in the areas of private equity, \u00a0private debt and real estate, we have witnessed that \u00a0there is more demand in realising such investments via \u00a0Luxembourg alternative investment fund structures \u00a0(the \u201cAIFs\u201d) by international eligible investors. In the EU, \u00a0AIFs were introduced by the Alternative Investment \u00a0Fund … Continued<\/a><\/p>\n","protected":false},"author":35,"featured_media":31052,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[630],"tags":[],"ausgabe":[],"class_list":["post-31564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media-review"],"acf":{"postdownloads_lux":[{"download_lux":31229,"anzeigetitel_lux":"DOWNLOAD"}],"pressekontakt":{"name":"","email":"","phone":""},"ansprechpartner":[{"anwalt":30546},{"anwalt":""}]},"_links":{"self":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/31564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/comments?post=31564"}],"version-history":[{"count":0,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/31564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media\/31052"}],"wp:attachment":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media?parent=31564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/categories?post=31564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/tags?post=31564"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/ausgabe?post=31564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}